Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
Repligen has a consensus price target of $201.83.
The stock price for Repligen (NASDAQ: RGEN) is $138.6 last updated September 25, 2024 at 12:31 PM EDT.
There are no upcoming dividends for Repligen.
Repligen’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.